Jeffrey A. Cook
Analyst · Goldman Sachs
Thank you, Frédéric. Moving to Slide 8. Fourth quarter net sales adjusted for constant currency decreased 5.4% versus the prior-year quarter. However, excluding the receipt of initial fees aggregating $12.6 million during the fourth quarter of 2011 on a new royalty agreement, revenue would have exceeded the prior-year period. Full year 2012 net sales adjusted for constant currency increased 5.4% versus 2011, driven by improved product mix. Turning to Slide 9 and our volume trends. Fourth quarter 2012 reconstituted tobacco sales volumes were down 2% compared to the prior-year period, due primarily to timing of orders. However, for the total year 2012, RTL volume is up 6%. Tobacco paper volumes, including CTM, our joint venture in China, increased by 1% versus the fourth quarter of 2011. Volumes at CTM increased 37% versus the third quarter of 2012, which reflects the expected second half improvement in volume we had previously communicated. Total SWM volumes, including China, were up 1% versus both the prior-year quarter and for the total year 2012 over 2011. On Slide 10, you will see that our full year adjusted operating profit increased $17.3 million or 11.6% versus 2011, as growth in LIP and RTL volume more than offset the negative impact of a weaker euro. 2012 pulp cost overall were essentially flat with 2011, as lower NBSK softwood prices have been offset by higher BEK hardwood prices. Our adjusted operating margin at constant currency for full year 2012 rose to 20.5%, up 190 basis points from 2011. As you will see on Slide 11, adjusted operating profit for fourth quarter of 2012 was down 33% from an exceptionally strong fourth quarter of 2011. Absent the impact of $12.6 million in initial fees received on a new royalty agreement in 2011, adjusted operating profit was down 13%. This decrease was driven by inventory write-offs related to shutdown of our Philippines mill, resolution of a nonrecurring quality issue and incurrence of special consulting fees related to longer-term strategic planning activities. Our fourth quarter 2012 adjusted earnings per share, as shown on Slide 12, was slightly lower than the $0.91 per share from the prior-year quarter. This comparison excludes the impact of initial fees received on a new royalty agreement during 2011, as can be seen on the slide. The slight decline in fourth quarter earnings is primarily the result of expenses related to the resolution of a quality issue and special consulting studies related to longer-term strategic planning. Full year adjusted earnings per share were $3.55, an 18% increase over increase in 2011. Our total year adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, was $211.2 million, an increase of 12% from total year 2011. Turning to Slide 13. SWM net debt decreased by $43.8 million during the fourth quarter of 2012 and is down $64.7 million from the end of 2011 despite $50 million of share repurchases, a midyear doubling of our dividend and a $20.9 million of equity investments into CTS, our new reconstituted tobacco joint venture under construction in China. Strong operating cash flow generation more than offset capital equipment requirements, share repurchases and dividend payments. Total debt was 23.4% of capital, and SWM's net debt to adjusted EBITDA ratio remains low at 0.02 as of December 31, 2012. Now moving to Slide 14. Capital spending was $27.2 million in 2012, well below the $60.9 million in 2011. 2011 capital spending included $30.8 million toward construction of the RTL facility in the Philippines to a mothball state and $9.2 million toward completion of the LIP printing facility in Poland. For 2013, we expect capital spending to be between $30 million and $35 million, slightly higher than 2012 levels but still well below 2011 spending. We expect 2013 equity investments for CTS to be less than half the amount we invested during 2012. Dividend payments will rise due to the 100% increase in our quarterly dividend payable on March 21, 2013 to shareholders of record on February 28, along with a full year impact of the 100% increase created in mid-2012 from the 2-for-1 stock split. This combined 400% increase in our quarterly dividend signals confidence in our growth strategy and our commitment to increased shareholder returns. Frédéric will discuss our capital allocation strategy in further detail in just a moment. Return on invested capital in 2012, as shown on Slide 15, was 21.2%, up from 18.7% in 2011 and well above our cost of capital, primarily due to increased adjusted net income in 2012 compared to 2011 and continued prudent use of capital. ROIC is expected to remain strong in 2013 due to higher earnings and relatively stable levels of invested capital. I will now turn the call back over to Frédéric to provide an overview of our capital allocation and growth strategies.
Frédéric P. Villoutreix: Thanks, Jeff. In keeping with our proven track record of judicious capital allocation, focus on innovation, long-term growth and superior shareholder value, we have mapped out our go-forward capital allocation strategy on Slide 16. First and foremost, we will invest in our core business when and where appropriate to continue building on the success of our highly differentiated products. This, in conjunction with the balance allocation of the capital, is expected to produce continued growth in EPS over the long term. Second, we will return at least 1/3 of free cash flow to shareholders via balanced dividends and share repurchase programs. Our announcement today of $50 million share repurchase program and a 1% increase in the quarterly dividend to reflect this commitment. Third and finally, we will remain opportunistic but prudent in pursuing growth opportunities in adjacent markets. Ultimately, our innovative and research-driven culture generates an expertise that can be successfully applied to other specialized tangential industries with attractive fundamentals. Any transaction will have to meet stringent criteria and be accretive in 12 months. Command margin similar to existing business and financed through a combination of cash, debt and equity. Finally, new investment opportunities will target an ROIC threshold in the range of 15% to 20%. Overall, SWM is committed to the optimal capital structure that allows for investment and growth while providing attractive returns to investors, and this without overly burdening our balance sheet. We believe this capital allocation strategy will help us to achieve our goal. With a clear capital allocation strategy in place, let's address our first priority, our core business growth. Slide 17 provides an overview of our growth strategy. SWM's focus on delivering superior customer value through continuous collaboration with our global partners to create custom-engineered solutions aims to produce sustainable annual long-term sales growth, starting with progressive global adoption of LIP and RTL. In addition, our commitment to operational excellence and taking cost out of the business should maintain, if not improve, our margin structure and continue to support EPS growth. We will enhance our profitability by also ensuring that our facilities and equipment are state-of-the-art in order to maximize our value to our customers. This is a core tenet of our future growth. Along those lines, we'll continue to invest in Asia, as we further strengthen our relationships in this region and demonstrate our technical expertise. By exiting operations in Indonesia and the Philippines, neither of which provided the proper footprint for operational capabilities to penetrate the Asia market meaningfully, we can better focus on our 2 existing China joint ventures while continuing to serve the LIP needs in Asia from other SWM operations. Finally, as a leading global provider of highly engineered and proprietary solutions for the tobacco industry, we can leverage our core strengths to introduce our existing products to new markets and enter adjacent markets with equally attractive economics. Specifically, the progressive expansion of LIP and RTL and nontobacco applications for engineered fine papers provide us with a valuable opportunity to leverage our existing product portfolio for both organic and inorganic growth. We have the requisite experience to integrate new businesses and deploy operational excellence best practices critical to the success of any expansion opportunity. And once again, acquisition in adjacent growth areas will be immediately accretive and provide economic returns and cash flows similar to existing business. Ultimately, it is our view that a diverse yet stable growth portfolio better positions SWM to weather market situations and improve infrastructure productivity. And a comprehensive growth strategy such as ours enables us to build this portfolio, generate strong cash flow and provide attractive shareholder returns. Let me now turn it over to Jeff for our financial guidance for 2013.